ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression

Table 1 Correlation between clinicopathological characteristics and ZEB1-AS1 or miR-149-3p

Parameter	Case number	ZEB1-AS1 expression		P-value	miR-149-3p expression		P-value
Parameter	Case number	High (n = 42)	Low (n = 42)	P-value	High (n = 42)	Low (n = 42)	P-value
Age (years)				0.507			0.268
< 60	35	19	16		20	15
≥ 60	49	23	26		22	27
Gender				0.124			0.826
Male	47	27	20		24	23
Female	37	15	22		18	19
Tumor size (cm)				0.02*			0.188
≤ 5	38	12	26		22	16
> 5	46	30	16		20	26
Differentiation				0.127			0.275
Well/moderate	43	18	25		24	19
Poor	41	24	17		18	23
Invasion depth				0.387			0.027*
T1–T2	36	16	20		23	13
T3–T4	48	26	22		19	29
Lymph node metastasis				0.01*			0.126
No	39	12	27		23	16
Yes	45	30	15		19	26
TNM stage				0.048*			0.04*
I–II	37	14	23		25	12
III–IV	47	28	19		17	30
CA-199 (tissue) (U/mL)				0.825			0.268
< 37	35	17	18		20	15
> 37	49	25	24		22	27

ISSN: 1475-2867